Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M4,694Revenue $M1,466Net Margin (%)44.5Altman Z-Score8.5
Enterprise Value $M3,746EPS $12.9Operating Margin %47.7Piotroski F-Score8
P/E(ttm)8.2Beneish M-Score-2.5Pre-tax Margin (%)71.3Higher ROA y-yY
Price/Book3.010-y EBITDA Growth Rate %--Quick Ratio2.7Cash flow > EarningsN
Price/Sales3.65-y EBITDA Growth Rate %37.0Current Ratio2.9Lower Leverage y-yY
Price/Free Cash Flow15.6y-y EBITDA Growth Rate %105ROA % (ttm)33.1Higher Current Ratio y-yY
Dividend Yield %--PEG0.2ROE % (ttm)50.7Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M44.6ROIC % (ttm)70.7Gross Margin Increase y-yY

Gurus Latest Trades with UTHR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
UTHRKen Fisher 2016-03-31 Reduce$108.47 - $156.61
($127.11)
$ 105.20-17%Reduce -1.43%3,092
UTHRFirst Eagle Investment 2015-12-31 Sold Out -0.18%$119.57 - $160.91
($146.21)
$ 105.20-28%Sold Out0
UTHRJoel Greenblatt 2015-12-31 Add0.05%$119.57 - $160.91
($146.21)
$ 105.20-28%Add 9.00%328,310
UTHRGeorge Soros 2015-12-31 Buy 0.01%$119.57 - $160.91
($146.21)
$ 105.20-28%New holding4,400
UTHRKen Fisher 2015-12-31 Add$119.57 - $160.91
($145.83)
$ 105.20-28%Add 7.51%3,137
UTHRJoel Greenblatt 2015-09-30 Add0.05%$131.24 - $179.15
($160.64)
$ 105.20-35%Add 15.35%301,205
UTHRFirst Eagle Investment 2015-09-30 Add0.04%$131.24 - $179.15
($160.64)
$ 105.20-35%Add 28.56%548,807
UTHRKen Fisher 2015-09-30 Add$131.24 - $179.15
($160.64)
$ 105.20-35%Add 19.10%2,918
UTHRJoel Greenblatt 2015-06-30 Reduce-0.04%$159.69 - $188.56
($179.77)
$ 105.20-41%Reduce -10.29%261,125
UTHRFirst Eagle Investment 2015-06-30 Add0.02%$159.69 - $188.56
($179.77)
$ 105.20-41%Add 14.57%426,880
UTHRJoel Greenblatt 2015-03-31 Reduce-0.03%$124.93 - $179.51
($152.45)
$ 105.20-31%Reduce -9.91%291,077
UTHRFirst Eagle Investment 2015-03-31 Add$124.93 - $179.51
($152.45)
$ 105.20-31%Add 3.44%372,580
UTHRKen Fisher 2015-03-31 Buy $124.93 - $179.51
($152.45)
$ 105.20-31%New holding2,450
UTHRFirst Eagle Investment 2014-12-31 Add0.03%$122.11 - $134.8
($128.83)
$ 105.20-18%Add 37.43%360,180
UTHRJoel Greenblatt 2014-09-30 Reduce-0.4%$86.44 - $136.16
($102.87)
$ 105.202%Reduce -55.36%288,401
UTHRFirst Eagle Investment 2014-09-30 Buy 0.08%$86.44 - $136.16
($102.87)
$ 105.202%New holding262,080
UTHRJoel Greenblatt 2014-06-30 Add0.37%$86.14 - $107.81
($96.29)
$ 105.209%Add 104.14%646,066
UTHRJoel Greenblatt 2014-03-31 Add0.17%$90.67 - $113.39
($102.75)
$ 105.202%Add 62.64%316,489
UTHRJoel Greenblatt 2013-12-31 Reduce-0.45%$80.03 - $114.51
($89.93)
$ 105.2017%Reduce -47.71%194,595
UTHRVanguard Health Care Fund 2013-09-30 Sold Out -0.32%$66.1 - $79.58
($73.08)
$ 105.2044%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

UTHR is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


UTHR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ROTHBLATT MARTINE AChairman & Co-CEO 2016-04-21Sell5,546$115.74-7.47view
ROTHBLATT MARTINE AChairman & Co-CEO 2016-04-14Sell5,547$114.32-6.32view
ROTHBLATT MARTINE AChairman & Co-CEO 2016-04-07Sell5,546$113.31-5.49view
ROTHBLATT MARTINE AChairman & Co-CEO 2016-03-24Sell5,546$110.8-3.35view
ROTHBLATT MARTINE AChairman & Co-CEO 2016-03-17Sell5,547$118.22-9.41view
ROTHBLATT MARTINE AChairman & Co-CEO 2016-03-10Sell5,546$123.41-13.22view
ROTHBLATT MARTINE AChairman & Co-CEO 2016-03-03Sell5,547$126.78-15.53view
Thompson Tommy GDirector 2016-03-01Sell3,000$126.54-15.37view
ROTHBLATT MARTINE AChairman & Co-CEO 2016-02-25Sell5,546$122.45-12.54view
ROTHBLATT MARTINE AChairman & Co-CEO 2016-02-18Sell5,547$128.26-16.51view

Quarterly/Annual Reports about UTHR:

News about UTHR:

Articles On GuruFocus.com
United Therapeutics Is a Value Investor's Biotech Dream Apr 28 2016 
Cummins and Deckers are Candidates for a January Bounce Nov 20 2015 
Estimated Revenue Up 5% Stock Screen Nov 18 2015 
FDA Approval Of Cancer Drug Catapults United Therapeutics Shares By 2% Mar 11 2015 
Weekly CFO Sells Highlight: United Therapeutics Corp, Williams Companies Inc, Facebook Inc. Oct 12 2014 
Here are 5 Good Companies to Consider Investing In Right Now Feb 11 2014 
High-Dollar Insider Sells - Zuckerberg Sells 41M Facebook Shares Dec 27 2013 
John Hussman's Third Quarter Top 5 Nov 07 2013 
Vanguard Health Care Fund Selling Update Oct 30 2013 
Super-Fast Growing Mid-Cap Growth Stocks with Explosive Returns May 09 2013 

More From Other Websites
The 52-Week Low Club for Thursday Apr 28 2016
Edited Transcript of UTHR earnings conference call or presentation 28-Apr-16 1:00pm GMT Apr 28 2016
Roger Jeffs out in executive shakeup at drugmaker United Therapeutics Apr 28 2016
United Therapeutics Corp Earnings Call scheduled for 9:00 am ET today Apr 28 2016
Q1 2016 United Therapeutics Corp Earnings Release - Before Market Open Apr 28 2016
UNITED THERAPEUTICS CORP Files SEC form 8-K, Change in Directors or Principal Officers Apr 28 2016
United Therapeutics Corporation Announces Executive Leadership Changes Apr 28 2016
United Therapeutics Corporation Reports First Quarter 2016 Financial Results Apr 28 2016
United Therapeutics beats 1Q profit forecasts Apr 28 2016
United Therapeutics beats 1Q profit forecasts Apr 28 2016
UNITED THERAPEUTICS CORP Files SEC form 10-Q, Quarterly Report Apr 28 2016
6:07 am United Therapeutics Co-CEO Roger Jeffs, Ph.D., and COO David Zaccardelli, Pharm.D. steps... Apr 28 2016
United Therapeutics Corporation Announces Executive Leadership Changes Apr 28 2016
United Therapeutics Corporation Reports First Quarter 2016 Financial Results Apr 28 2016
United Therapeutics Corporation To Present At Deutsche Bank 41st Annual Health Care Conference Apr 27 2016
United Therapeutics Corporation To Present At Deutsche Bank 41st Annual Health Care Conference Apr 27 2016
SteadyMed Announces Public Availability of PTAB Decision to Institute Inter Partes Review... Apr 25 2016
United Therapeutics Corporation To Announce First Quarter 2016 Financial Results Before Market Open... Apr 20 2016
United Therapeutics Corporation To Announce First Quarter 2016 Financial Results Before Market Open... Apr 20 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)